Anastasia Zimina

发表论文 20 篇 · 总被引 574 次 · h-index 6

代表论文

• Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial (2024 · BMJ · 被引 266)
• Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR -Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301 (2023 · Journal of Clinical Oncology · 被引 144)
• Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer (2025 · JAMA · 被引 44)
• RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 37)
• Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis (2023 · Journal of Thoracic Oncology · 被引 30)
• First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial (2025 · 癌症：英文版 · 被引 21)